This Week in Nature | GenomeWeb

This Week in Nature

In Nature Biotechnology this week, a team led by Massachusetts Institute of Technology researchers report on the use of a gene-editing approach called CRISPR to correct a disease mutation and phenotype in mice, furthering the therapeutic potential of the technology. In the study, the scientists were able to deliver into the animals the Cas9 nuclease, along with a snippet of RNA that directed the enzyme to a specific portion of DNA where it causes double-strand breaks.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in Nature

This Week in Science

Not the Fittest

This Week in Science

This Week in PNAS

This Week in Nature

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.